Clinical trials: Stool Frequency
- Condition Stool Frequency
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Stool Frequency
A Prospective, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy of Bacillus Coagulans Unique IS2 on Improving Bowel Movement Characteristics, Gastrointestinal-related Symptoms and Quality of Life in Healthy Adult Participants
This prospective, randomized, placebo-controlled, double-blind study will be conducted to assess the efficacy of 2 billion CFU/day of B.
- Trial name
- NCT05123664
- Testing
- Capsule
- Where
- Canada
- Volunteers
- 143 people, healthy volunteers welcome
- Sponsor
- PepsiCo Global R&D